Cosson E, Banu I, Cussac-Pillegand C, Chen Q, Chiheb S, Jaber Y, Nguyen MT, Charnaux N, Valensi P. Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes. Diabetes Care. 2013;36:2070-2076

Delcombel R, Janssen L, Vassy R, Gammons M, Haddad O, Richard B, Letourneur D, Bates D, Hendricks C, Waltenberger J, Starzec A, Sounni NE, Noël A, Deroanne C, Lambert C, Colige A. New prospects in the roles of the c-terminal domains of vegf-a and their cooperation for ligand binding, cellular signaling and vessels formation. Angiogenesis. 2013;16:353-371

Cosson E, Chiheb S, Cussac-Pillegand C, Banu I, Hamo-Tchatchouang E, Nguyen MT, Aout M, Charnaux N,Valensi P. Haemoglobin glycation may partly explain the discordance between HbA1c measurement and oral glucose tolerance test to diagnose dysglycaemia in overweight/obese subjects. Diabetes Metab. 2013;39:118-25

Guyot E, Chevallier A, Barouki R, Coumoul X. The AhR twist: Ligand-dependent ahr signaling and pharmaco-toxicological implications. Drug Discovery Today. 2013;18:479-486

Guyot E, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Beaugrand M, Charnaux N, Trinchet J-C, Nahon P. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. Journal of Hepatology. 2013;58:312-318

Nault J-C, Guyot E, Laguillier C, Chevret S, Ganne-Carrie N, N'Kontchou G, Beaugrand M, Seror O, Trinchet J-C, Coelho J, Lasalle P, Charnaux N, Delehedde M, Sutton A, Nahon P. Serum proteoglycans as prognostic biomarkers of hepatocellular carcinoma in patients with alcoholic cirrhosis. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2013;22:1343-1352

Soussan M, Chouahnia K, Maisonobe J-A, Boubaya M, Eder V, Morère J-F, Buvat I. Prognostic implications of volume-based measurements on fdg pet/ct in stage iii non-small-cell lung cancer after induction chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 2013;40:668-676

Soussan M, Pop G, Eder V. [current applications of pet/ct].La Revue Du Praticien. 2013;63:1199-1207

Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, Méjean C, Latino-Martel P, Hercberg S, Galan P, Czernichow S. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: A nested case-control study. American Journal of Epidemiology. 2013;177:3-13

ZIOL M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, Blanc J-F, Sturm N, Bioulac-Sage P, Nahon P, Nault J-C, Charnaux N, N'Kontchou G, Trinchet J-C, Delehedde M, Seror O, Beaugrand M, Vicaut E, Ganne-Carrié N. Esm-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. Journal of Hepatology. 2013;59:1264-1270